-
31.
公开(公告)号:CY1115750T1
公开(公告)日:2017-01-25
申请号:CY141100743
申请日:2014-09-15
Applicant: VERTEX PHARMA
Inventor: HADIDA RUAH SARA , HAMILTON MATTHEW , MILLER MARK , GROOTENHUIS PETER D J , BEAR BRIAN , MCCARTHY JASON , ZHOU JINGLAN
IPC: C07D405/12 , A61K31/443 , A61P11/00
Abstract: ΟιφαρμακευτικώςαποδεκτέςσυνθέσειςτηςπαρούσαςεφεύρεσηςείναιχρήσιμεςωςδιαμορφωτέςμεταφορέωνκασέταςσύνδεσηςμεΑΤΡ ("ΑΒC") τωνθραυσμάτωντους, περιλαμβανομένουτουρυθμιστήδιαμεμβρανικήςαγωγιμότηταςκυστικήςίνωσης ("CFTR").
-
公开(公告)号:CA2716109C
公开(公告)日:2016-07-19
申请号:CA2716109
申请日:2009-02-25
Applicant: VERTEX PHARMA
Inventor: HADIDA-RUAH SARA , MILLER MARK , ZHOU JINGLAN , BEAR BRIAN
IPC: C07D405/12 , A61K31/443 , A61P11/00 , G01N33/48
Abstract: The present invention relates to modulators of ATP-B inding Cassette ('ABC') transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ('CFTR'), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
-
公开(公告)号:NZ703814A
公开(公告)日:2016-06-24
申请号:NZ70381409
申请日:2009-02-25
Applicant: VERTEX PHARMA
Inventor: HADIDA-RUAH SARA , MILLER MARK , ZHOU JINGLAN , BEAR BRIAN
IPC: C07D239/42 , A61K31/435 , A61K31/4965 , A61K31/505 , A61P3/00 , A61P25/00 , C07D213/75 , C07D241/20
Abstract: Disclosed herein are 1-(benzo[d][1,3]dioxol-5-yl)-carboxamide compounds of formula (I), wherein the substituents are as defined in the specification, processes for its preparation, compositions comprising said compound and uses thereof. These compounds are useful as modulators of ATP-Binding Cassette (ABC) transporter or fragments thereof and is therefore useful in the treatment of condition, disease or disorders selected from cystic fibrosis, hereditary emphysema, hereditary hemochromatosis, protein C deficiency, Type 1 hereditary angioedema, familial hypercholesterolemia, Type 1 chylomicronemia, abetalipoproteinemia, I-cell disease/pseudo-Hurler, mucopolysaccharidoses, Sandhof/Tay-Sachs, Crigler-Najjar type II, polyendocrinopathy/hyperinsulemia, diabetes mellitus, laron dwarfism, myeloperoxidase deficiency, primary hypoparathyroidism, melanoma, glycanosis CDG type 1, hereditary emphysema, congenital hyperthyroidism, osteogenesis imperfecta, hereditary hypofibrinogenemia, ACT deficiency, diabetes insipidus (di), neurophyseal di, neprogenic DI, Charcot-Marie Tooth syndrome, Perlizaeus-Merzbacher disease, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, progressive supranuclear plasy, Pick’s disease, Huntington, spinocerebullar ataxia type I, spinal and bulbar muscular atrophy, dentatorubal pallidoluysian, myotonic dystrophy, hereditary Creutzfeldt-Jakob disease, Fabry disease, Straussler-Scheinker syndrome, COPD, dry-eye disease, and Sjögren’s disease.
-
公开(公告)号:SI2578571T1
公开(公告)日:2016-01-29
申请号:SI200831546
申请日:2008-11-14
Applicant: VERTEX PHARMA
Inventor: HADIDA RUAH SARA , MILLER MARK , ZHOU JINGLAN , BEAR BRIAN , GROOTENHUIS PETER D J
IPC: C07D217/00 , A61K31/00 , A61P11/00 , C07D401/00 , C07D405/00
-
公开(公告)号:AU2015228930A1
公开(公告)日:2015-11-05
申请号:AU2015228930
申请日:2015-09-21
Applicant: VERTEX PHARMA
Inventor: HADIDA-RUAH SARA , MILLER MARK , ZHOU JINGLAN , BEAR BRIAN
IPC: C07D213/75 , A61K31/435 , A61K31/4965 , A61K31/505 , A61P3/00 , A61P25/00 , C07D239/42 , C07D241/20
Abstract: The present invention relates to modulators of ATP-Binding Cassette ('ABC') transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ('CFTR'), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
-
公开(公告)号:DK2578571T3
公开(公告)日:2015-10-05
申请号:DK12181370
申请日:2008-11-14
Applicant: VERTEX PHARMA
Inventor: HADIDA RUAH SARA , MILLER MARK , ZHOU JINGLAN , BEAR BRIAN , GROOTENHUIS PETER D J
IPC: C07D217/22 , A61K31/472 , A61K31/4725 , A61P11/00 , C07D401/04 , C07D405/12 , C07D405/14
-
公开(公告)号:AU2013231026B2
公开(公告)日:2015-09-17
申请号:AU2013231026
申请日:2013-09-17
Applicant: VERTEX PHARMA
Inventor: HADIDA RUAH SARA , ZHOU JINGLAN , MILLER MARK , BEAR BRIAN
IPC: C07D471/04 , A61K31/437 , A61P3/00 , A61P25/00
Abstract: The present invention relates to modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
-
公开(公告)号:AU2013205162B2
公开(公告)日:2015-07-09
申请号:AU2013205162
申请日:2013-04-14
Applicant: VERTEX PHARMA
Inventor: HADIDA-RUAH SARA , MILLER MARK , ZHOU JINGLAN , BEAR BRIAN
IPC: C07D213/75 , A61K31/435 , A61K31/4965 , A61K31/505 , A61P3/00 , A61P25/00 , C07D239/42 , C07D241/20
Abstract: The present invention relates to modulators of ATP-Binding Cassette ('ABC') transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ('CFTR'), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
-
39.
公开(公告)号:SI2395002T1
公开(公告)日:2014-10-30
申请号:SI200631826
申请日:2006-11-08
Applicant: VERTEX PHARMA
Inventor: HADIDA RUAH SARA , HAMILTON MATTHEW , MILLER MARK , GROOTENHUIS PETER D J , BEAR BRIAN , MCCARTHY JASON , ZHOU JINGLAN
IPC: C07D405/00 , A61K31/00 , A61P11/00
-
公开(公告)号:SI1945632T1
公开(公告)日:2014-03-31
申请号:SI200631716
申请日:2006-11-08
Applicant: VERTEX PHARMA
Inventor: HADIDA RUAH SARA , HAMILTON MATTHEW , MILLER MARK , GROOTENHUIS PETER D J , BEAR BRIAN , MCCARTHY JASON , ZHOU JINGLAN
IPC: C07D405/00 , A61K31/00 , A61P11/00 , C07D213/00
-
-
-
-
-
-
-
-
-